What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
His scientific interests lie mostly in Internal medicine, Endocrinology, Angiotensin II, Renin–angiotensin system and Receptor.
Mohan K. Raizada incorporates Internal medicine and Angiotensin-converting enzyme 2 in his research.
Insulin, Blood pressure, Angiotensin II receptor type 1, Stimulation and Central nervous system are the core of his Endocrinology study.
The concepts of his Angiotensin II study are interwoven with issues in Spontaneously hypertensive rat, Lamina terminalis and Neuroscience, Neuron.
His study focuses on the intersection of Renin–angiotensin system and fields such as Pharmacology with connections in the field of Enzyme, Disease, Regulator, Cardiovascular physiology and Genetic enhancement.
His Receptor research includes elements of Biological activity, Signal transduction and Molecular biology.
His most cited work include:
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. (588 citations)
- Gut Dysbiosis Is Linked to Hypertension (530 citations)
- Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1–7) (272 citations)
What are the main themes of his work throughout his whole career to date?
Mohan K. Raizada focuses on Internal medicine, Endocrinology, Angiotensin II, Receptor and Renin–angiotensin system.
Mohan K. Raizada integrates many fields, such as Internal medicine and Angiotensin-converting enzyme 2, in his works.
His research in Endocrinology intersects with topics in Cell culture and Neuron.
He interconnects Molecular biology and Protein kinase C in the investigation of issues within Angiotensin II.
His Receptor research incorporates elements of Binding site and Cell biology.
His studies deal with areas such as Diabetes mellitus, Angiotensin-converting enzyme, Central nervous system, Enzyme and Pharmacology as well as Renin–angiotensin system.
He most often published in these fields:
- Internal medicine (61.90%)
- Endocrinology (57.65%)
- Angiotensin II (32.99%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (61.90%)
- Endocrinology (57.65%)
- Angiotensin II (32.99%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Endocrinology, Angiotensin II, Renin–angiotensin system and Blood pressure.
His Internal medicine study integrates concerns from other disciplines, such as Progenitor cell and Cardiology.
He has included themes like Proinflammatory cytokine and Bone marrow in his Endocrinology study.
His work carried out in the field of Angiotensin II brings together such families of science as Cancer research, Homing and Cell biology.
His Renin–angiotensin system study combines topics from a wide range of disciplines, such as Diabetes mellitus, Receptor, Pharmacology and Enzyme.
His work in Blood pressure tackles topics such as Gut flora which are related to areas like Endothelial dysfunction.
Between 2011 and 2021, his most popular works were:
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. (588 citations)
- Gut Dysbiosis Is Linked to Hypertension (530 citations)
- Discovery and Characterization of Alamandine A Novel Component of the Renin–Angiotensin System (214 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Mohan K. Raizada mainly investigates Internal medicine, Endocrinology, Angiotensin II, Renin–angiotensin system and Blood pressure.
His research investigates the link between Internal medicine and topics such as Diabetes mellitus that cross with problems in Oxidative stress.
In general Endocrinology, his work in Endothelial dysfunction is often linked to Angiotensin-converting enzyme 2 linking many areas of study.
His Angiotensin II study incorporates themes from Hypothalamus, Angiotensin-converting enzyme, Receptor antagonist and Vasodilation.
His study in Renin–angiotensin system is interdisciplinary in nature, drawing from both Receptor, Cytokine, Pharmacology and Endothelial progenitor cell.
The study incorporates disciplines such as Gut flora, Dysbiosis and Immune system in addition to Blood pressure.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
